Silicon Investor (SI) -- The First Internet Community

STOCKTALK

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor. We ask that you disable ad blocking while on Silicon Investor in the best interests of our community. If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.

Microcap & Penny Stocks : AMERICAN BIOMED, Minimally Invasive Technology (ABMI) -- Ignore unavailable to you. Want to Upgrade?

To: greg Benfield who wrote (1416)	7/8/1998 10:52:00 AM
From: Jeffrey L. Henken	Read Replies (1) \| Respond to of 2887

Steve told me American BioMed is doing everything they can to get CE Mark approval as quickly as possible. The regulatory body for the EC has a huge backlog of paperwork. It's only a matter of time before we see ABMI achieve CE Mark approval. I honestly don't know it Vitalitec can start selling these products in France without CE Mark approval but it seems to me that they intend to do so as quickly as possible from the way I read the following statements: Commenting for Vitalitec, Managing Director Jacques Le Bozec said, ''We are most excited about promoting American BioMed products. With our vast experience in the vascular market, we should realize strong sales with their silicone catheter products.'' Vitalitec has placed initial stocking orders and training will begin this quarter. Regards, Jeff